(+)-Dinapsoline: An Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist
作者:Sing-Yuen Sit、Kai Xie、Swanee Jacutin-Porte、Matthew T. Taber、Amit G. Gulwadi、Carolyn D. Korpinen、Kevin D. Burris、Thaddeus F. Molski、Elaine Ryan、Cen Xu、Henry Wong、Juliang Zhu、Subramaniam Krishnananthan、Qi Gao、Todd Verdoorn、Graham Johnson
DOI:10.1021/jm0101545
日期:2002.8.1
highly convergent synthesis was developed for the novel dopamine agonist dinapsoline (12) (Ghosh, D.; Snyder, S. E.; Watts, V. J.; Mailman, R. B.; Nichols, D. E. 8,9-Dihydroxy-2,3,7, 11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: A Potent Full Dopamine D(1) Agonist Containing a Rigid beta-Phenyldopamine Pharmacophore. J. Med. Chem. 1996, 39 (2), 549-555). The crucial step in the new synthesis was a free radical-initiated
对于新型多巴胺激动剂地那普林(12)(Ghosh,D .; Snyder,SE; Watts,VJ; Mailman,RB; Nichols,DE 8,9-Dihydroxy-2,3,7,11b- tetrahydro-1H-naph [1,2,3-de] isoquinoline:强有力的全多巴胺D(1)激动剂,包含刚性β-苯基多巴胺Pharmacophore。J. Med。Chem。1996,39(2),549-555) 。新合成中的关键步骤是自由基引发的环化反应,以提供完整的地那萘林骨架。改进的合成所需的步骤是原始步骤的一半(Nichols,DE; Mailman,R; Ghosh,D。制备新型萘并[1,2,3-de]异喹啉作为多巴胺受体配体的方法。 WO 9706799 A1,1997年2月27日)。一种晚期中间体(11)被拆分为一对对映异构体。从那里,地那辛的(R)-(+)-12